button bars forest bayes pooled summary circles
 
Statistically conclusive or suggested result Inconclusive results Uncertain results Safety results

mHCC - 1st line (L1) metastatic/advanced hepatocellular cancer (mHCC) mHCC - 1st line (L1)

versus placebo
durvalumab plus bevacizumab vs. placebo 1

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons